Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases

It is estimated that about 5–10% of ovarian and 2–5% of all breast cancer patients are carriers of a germline BRCA1 or BRCA2 gene mutation. Most families with detected BRCA1 or BRCA2 gene mutation are qualified for molecular testing on the basis of family history of breast or ovarian cancers. The pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Brozek, Izabela, Ratajska, Magdalena, Piatkowska, Magdalena, Kluska, Anna, Balabas, Aneta, Dabrowska, Michalina, Nowakowska, Dorota, Niwinska, Anna, Rachtan, Jadwiga, Steffen, Jan, Limon, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496543/
https://www.ncbi.nlm.nih.gov/pubmed/22395474
http://dx.doi.org/10.1007/s10689-012-9519-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496543/
https://www.ncbi.nlm.nih.gov/pubmed/22395474
http://dx.doi.org/10.1007/s10689-012-9519-5

Ejemplares similares